This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Bio-Rad Laboratories, Inc.. Active years: 1999-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2000
Title: Caroline Scolari: Innovator in Biological Sample Analysis
Introduction
Caroline Scolari is a prominent inventor based in Albany, CA (US). She has made significant contributions to the field of biological sample analysis, particularly in the detection and quantification of paraproteins. With a total of 2 patents, her work has advanced the methodologies used in clinical diagnostics.
Latest Patents
Caroline's latest patents include "Computer directed identification of paraproteins" and "Computer-directed detection of paraproteins." The first patent focuses on the automated analysis of biological samples using immunosubtraction, capillary electrophoresis, and Fourier transformation analysis. The second patent details a method for identifying and quantifying paraproteins in a sample through Fourier analysis of mobility-based electropherograms obtained from capillary electrophoresis. This innovative approach allows clinicians to detect levels of paraproteins in serum as low as 0.05 g/dL, providing valuable insights into individual health conditions.
Career Highlights
Caroline Scolari is currently employed at Bio-Rad Laboratories, Inc., where she continues to develop her groundbreaking technologies. Her work has not only enhanced the accuracy of paraprotein detection but has also contributed to the overall improvement of diagnostic practices in the medical field.
Collaborations
Some of Caroline's notable coworkers include Steven R. Binder and Robert K. Likuski. Their collaborative efforts have further propelled advancements in the field of biological analysis.
Conclusion
Caroline Scolari's innovative contributions to the analysis of biological samples have established her as a key figure in the field. Her patents reflect a commitment to improving diagnostic methods, ultimately benefiting clinicians and patients alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
